Evaluation of 'see-see and treat' strategy and role of HIV on cervical cancer prevention in Uganda.
BACKGROUND
There is scant information on whether Human Immunodeficiency Virus (HIV) seropositivity has an influence on the outcome of treatment of precancerous cervical lesions using cryotherapy. We studied the prevalence of cervical abnormalities detectable by visual inspection and cervical lesions diagnosed by colposcopy according to HIV serostatus and described the outcomes of cryotherapy treatment.


METHODS
Trained nurses examined women not previously screened for cervical cancer using visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) in two family planning/post natal clinics in Kampala, Uganda, from February 2007 to August 2008. Women with abnormal visual inspection findings were referred for colposcopic evaluation and HIV testing. Women with precancerous cervical lesions detected at colposcopy were treated mainly by cryotherapy, and were evaluated for treatment outcome after 3 months by a second colposcopy.


RESULTS
Of the 5 105 women screened, 834 presented a positive screening test and were referred for colposcopy. Of these 625 (75%) returned for the colposcopic evaluation and were tested for HIV. For the 608 (97.5%) women in the age range 20-60 years, colposcopy revealed 169 women with cervical lesions: 128 had inflammation, 19 had low grade squamous intraepithelial lesion (LGSIL), 13 had high grade squamous intraepithelial lesion (HGSIL), 9 had invasive cervical cancer and 2 had inconclusive findings. Detection rates per 1 000 women screened were higher among the older women (41-60 years) compared to women aged 20-40 years. They were accordingly 55% and 20% for inflammation, 10% and 2% for LGSIL, 5% and 2% for HGSIL, 6% and 1% for invasive cervical cancer.Of the 608 women, 103 (16%) were HIV positive. HIV positivity was associated with higher likelihood of inflammation (RR = 1.7; 95% CI: 1.2-2.4).


CONCLUSIONS
Detection rates were higher among older women 41-60 years. Visual inspection of the cervix uteri with acetic acid (VIA) and Lugol's iodine (VILI) used as a sole method for cervical cancer screening would entail significant false positive results. HIV seropositivity was associated with a higher prevalence of inflammatory cervical lesions. In view of the small numbers and the relatively short follow up time of 3 months, we could not make an emphatic conclusion about the effect of HIV serostatus on cryotherapy treatment outcome.
Mutyaba
Twaha
T
Department of Obstetrics and Gynecology, Makerere University, Medical School, P,O, Box 7072, Kampala, Uganda. tmutyaba@yahoo.com.
Mirembe
Florence
F
Sandin
Sven
S
Weiderpass
Elisabete
E
Lancet Oncol. 2005 Jan;6(1):43-50
15629275
Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S251-61
16188303
Lancet Infect Dis. 2009 Jun;9(6):347-56
19467474
Eur J Obstet Gynecol Reprod Biol. 2002 Feb 10;101(1):64-9
11803102
Int J Cancer. 1992 Jun 19;51(4):515-21
1318265
Int J Gynaecol Obstet. 2005 May;89 Suppl 2:S21-9
15823263
J Fam Pract. 1994 Jul;39(1):65-70
7517993
J Infect Dis. 2008 Feb 15;197(4):555-62
18237268
Gynecol Obstet Invest. 2007;63(4):222-8
17191009
J Med Virol. 2008 May;80(5):847-55
18360898
Nurs Prax N Z. 2005 Nov;21(3):13-23
16764158
Sex Transm Infect. 1999 Feb;75(1):3-17
10448335
J Infect Dis. 1996 Mar;173(3):714-7
8627037
Hosp Med. 2002 Apr;63(4):218-23
11995272
Curr Opin HIV AIDS. 2009 Jan;4(1):68-73
19339941
Int J Cancer. 1989 May 15;43(5):805-9
2714885
N Engl J Med. 2009 Apr 2;360(14):1385-94
19339719
AIDS Behav. 2008 Mar;12(2):232-43
17828450
Obstet Gynecol. 2008 Jun;111(6):1388-93
18515523
Bull World Health Organ. 2001;79(2):127-32
11242819
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):483-8
12010863
N Engl J Med. 1997 Nov 6;337(19):1343-9
9358128
Int J Gynaecol Obstet. 2005 May;89 Suppl 2:S4-S12
15823266
BMC Cancer. 2006 May 23;6:135
16719902
Br J Cancer. 2000 May;82(9):1585-92
10789729
Acta Oncol. 1997;36(2):119-28
9140427
Int J Gynaecol Obstet. 2005 May;89 Suppl 2:S55-9
15823268
Am J Obstet Gynecol. 2006 Mar;194(3):704-10
16522401
Br J Cancer. 2007 Mar 12;96(5):738-43
17311015
Dis Markers. 2007;23(4):213-27
17627057
Int J Gynaecol Obstet. 2008 May;101(2):172-7
18207146
J Pathol. 1999 Sep;189(1):12-9
10451482
Nurse Pract. 1998 Apr;23(4):101-2, 108-10, 113-4
9579352
Cancer. 2008 Jun 15;112(12):2683-9
18438877
Int J STD AIDS. 2006 Sep;17(9):579-84; quiz 585-7
16942648
JAMA. 1993 Feb 10;269(6):729-30
8093740
Sex Transm Dis. 1992 Mar-Apr;19(2):61-77
1595015
Int J Technol Assess Health Care. 2009 Apr;25(2):161-70
19366497